The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2023
Filed:
Mar. 07, 2019
Applicant:
University of Notre Dame Du Lac, South Bend, IN (US);
Inventor:
Steven Buechler, Granger, IN (US);
Assignee:
University of Notre Dame du Lac, South Bend, IN (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G16H 20/40 (2018.01); G16H 70/60 (2018.01); G16H 10/40 (2018.01); G16H 50/20 (2018.01); G16B 25/10 (2019.01); G16B 40/00 (2019.01); G16B 30/00 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G16B 25/10 (2019.02); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16H 10/40 (2018.01); G16H 20/40 (2018.01); G16H 50/20 (2018.01); G16H 70/60 (2018.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01);
Abstract
Products, systems, and methods for classifying human colorectal cancer into a consensus molecular subtype (CMS) and for assessing risk of recurrence based on CMS scores and based on risk scores derived from abbreviated gene expression profiles, for determining suitable treatment protocols for human colorectal cancer patients based on the determined CMS classification and based on the determined risk of recurrence, and for administering the suitable treatment protocols.